Kumar Singh Saikatendu

2.8k citations

21 papers · 1.4k indexed · 1 hit paper · h-index 15

Infectious Diseases top 2%
Molecular Biology
Animal Science and Zoology top 2%
Computational Theory and Mathematics top 2%
Immunology

Co-authors: Raymond C. Stevens Michael J. Buchmeier Peter Kühn Jeremiah S. Joseph Benjamin W. Neuman Vanitha Subramanian Naina Barretto Andrew D. Mesecar
Topics: SARS-CoV-2 and COVID-19 Research (8 papers)Protein Structure and Dynamics (4 papers)Viral gastroenteritis research and epidemiology (4 papers)
Cited by: Infectious Diseases Animal Science and Zoology Computational Theory and Mathematics
Journals: Proceedings of the National Academy of Sciences Journal of Molecular Biology Nature Reviews Drug Discovery
Partner nations: United States Japan France

In The Last Decade

Kumar Singh Saikatendu

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accelerating antiviral drug discovery: lessons from COVID-19

2023 98 citations Annette von Delft, Matthew D. Hall et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Kumar Singh Saikatendu

Since Specialization

Citations

This map shows the geographic impact of Kumar Singh Saikatendu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar Singh Saikatendu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar Singh Saikatendu more than expected).

Fields of papers citing papers by Kumar Singh Saikatendu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumar Singh Saikatendu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar Singh Saikatendu. The network helps show where Kumar Singh Saikatendu may publish in the future.

Co-authorship network of co-authors of Kumar Singh Saikatendu

This figure shows the co-authorship network connecting the top 25 collaborators of Kumar Singh Saikatendu. A scholar is included among the top collaborators of Kumar Singh Saikatendu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar Singh Saikatendu. Kumar Singh Saikatendu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design 2025 ·Journal of Medicinal Chemistry ·(unknown),Daniel W. Carney,Michiko Tawada,(unknown),Jumpei Aida,Terufumi Takagi,Douglas R. Dougan,Abba E. Leffler,(unknown),Leah L. Frye,Eileen Hickey,(unknown),(unknown),Jangir Selimkhanov,Kazuko Yonemori,(unknown),Kumar Singh Saikatendu,Atsuko Ochida	0
2	Antiviral target compound profile for pandemic preparedness 2024 ·Nature Reviews Drug Discovery ·James F. Demarest,Ruxandra Draghia‐Akli,Tomáš Cihlář,Kenneth A. Bradley,John A. T. Young,Richa Chandra,Sujata Vaidyanathan,Margaret Y. Chu‐Moyer,Christopher J. Lynch,Andrew Campbell,Kumar Singh Saikatendu,John P. Bilello,Yoshihiko Murata,Marnix Van Loock,Aeron C. Hurt,Timothy L. Tellinghuisen,Luigi Ruggiero,Richard L. Mackman,(unknown),John C. Pottage,(unknown),(unknown)	1
3	Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity 2024 ·Bioorganic & Medicinal Chemistry ·Daniel W. Carney,Abba E. Leffler,Jeffrey A. Bell,(unknown),Cecilia Y. Cheng,(unknown),(unknown),Douglas R. Dougan,Leah L. Frye,(unknown),Tim Knehans,Jennifer L. Knight,(unknown),Weston Lane,Hubert Li,(unknown),(unknown),Kumar Singh Saikatendu,(unknown),(unknown)	4
4	Accelerating antiviral drug discovery: lessons from COVID-19breakdown → 2023 ·Nature Reviews Drug Discovery ·Annette von Delft,Matthew D. Hall,Ann D. Kwong,Lisa A. Purcell,Kumar Singh Saikatendu,Uli Schmitz,John A. Tallarico,Alpha A. Lee	98
5	Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design 2020 ·ACS Omega ·Ikuo Fujimori,Takeshi Wakabayashi,(unknown),(unknown),Tsuyoshi Ishii,Aaron P. McGrath,Hua Zou,Kumar Singh Saikatendu,Hiroshi Imoto	2
6	Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors 2019 ·Journal of Medicinal Chemistry ·Makoto Fushimi,Ikuo Fujimori,Takeshi Wakabayashi,Tomoaki Hasui,Youichi Kawakita,(unknown),Tomoko Kato,(unknown),Tsuyoshi Ishii,(unknown),(unknown),Atsushi Nakatani,(unknown),Maki Miyamoto,Kumar Singh Saikatendu,Hua Zou,(unknown),J. David Lawson,Hiroshi Imoto	18
7	Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐b]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2 2019 ·ChemMedChem ·(unknown),Masashi Takahashi,(unknown),Rei Okamoto,Shinji Morimoto,(unknown),Takahiro Miyazaki,(unknown),(unknown),Tomohiro Kawamoto,Toshimasa Tanaka,(unknown),Terufumi Takagi,Hiroshi Sugimoto,Kengo Okada,Weston Lane,Bi‐Ching Sang,Kumar Singh Saikatendu,Shin-ichiro Matsunaga,(unknown)	3
8	Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H -pyrazolo[3,4- c ]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships 2018 ·Journal of Medicinal Chemistry ·Masato Yoshikawa,Morihisa Saitoh,Taisuke Katoh,Tomohiro Seki,(unknown),Yūji Shimizu,Tsuyoshi Ishii,(unknown),Masako Kuno,(unknown),(unknown),Kumar Singh Saikatendu,Hua Zou,Masanori Nakakariya,(unknown),(unknown),Takatoshi Yogo	91
9	Identification of PARP14 inhibitors using novel methods for detecting auto-ribosylation 2017 ·Biochemical and Biophysical Research Communications ·(unknown),Shin-ichi Matsumoto,(unknown),Kumar Singh Saikatendu,(unknown),Kazuko Yonemori,(unknown),Tsuyoshi Ishii,Tomohiro Kawamoto	21
10	A Fragment-Based Approach to IdentifyingS-Adenosyl-l-methionine -Competitive Inhibitors of CatecholO-Methyl Transferase (COMT). 2014 ·Journal of Medicinal Chemistry ·Marion Lanier,Géza Ambrus,Derek C. Cole,Richard Davenport,(unknown),Richard Fosbeary,Andy Jennings,(unknown),Yusuke Kamada,Ruhi Kamran,Shin-ichi Matsumoto,Atsushi Mizukami,(unknown),Kengo Okada,Kumar Singh Saikatendu,(unknown),Haihong Wu,Mark S. Hixon	10
11	Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3 2008 ·Journal of Virology ·Benjamin W. Neuman,Jeremiah S. Joseph,Kumar Singh Saikatendu,Pedro Serrano,Amarnath Chatterjee,Margaret A. Johnson,Lujian Liao,Joseph P. Klaus,John R. Yates,Kurt Wüthrich,Raymond C. Stevens,Michael J. Buchmeier,Peter Kühn	151
12	Nuclear Magnetic Resonance Structure Shows that the Severe Acute Respiratory Syndrome Coronavirus-Unique Domain Contains a Macrodomain Fold 2008 ·Journal of Virology ·Amarnath Chatterjee,Margaret A. Johnson,Pedro Serrano,Bill Pedrini,Jeremiah S. Joseph,Benjamin W. Neuman,Kumar Singh Saikatendu,Michael J. Buchmeier,Peter Kühn,Kurt Wüthrich	42
13	Crystal Structure and DNA Binding of the Homeodomain of the Stem Cell Transcription Factor Nanog 2007 ·Journal of Molecular Biology ·Ralf Jauch,Calista Keow Leng Ng,Kumar Singh Saikatendu,Raymond C. Stevens,Prasanna R. Kolatkar	66
14	Nuclear Magnetic Resonance Structure of the N-Terminal Domain of Nonstructural Protein 3 from the Severe Acute Respiratory Syndrome Coronavirus 2007 ·Journal of Virology ·Pedro Serrano,Margaret A. Johnson,Marcius S. Almeida,Reto Horst,Torsten Herrmann,Jeremiah S. Joseph,Benjamin W. Neuman,Vanitha Subramanian,Kumar Singh Saikatendu,Michael J. Buchmeier,Raymond C. Stevens,Peter Kühn,Kurt Wüthrich	74
15	Crystal Structure of a Monomeric Form of Severe Acute Respiratory Syndrome Coronavirus Endonuclease nsp15 Suggests a Role for Hexamerization as an Allosteric Switch 2007 ·Journal of Virology ·Jeremiah S. Joseph,Kumar Singh Saikatendu,Vanitha Subramanian,Benjamin W. Neuman,Michael J. Buchmeier,Raymond C. Stevens,Peter Kühn	72
16	Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein 2007 ·Journal of Virology ·Kumar Singh Saikatendu,Jeremiah S. Joseph,Vanitha Subramanian,Benjamin W. Neuman,Michael J. Buchmeier,Raymond C. Stevens,Peter Kühn	117
17	Structure of a conserved hypothetical protein SA1388 from S. aureus reveals a capped hexameric toroid with two PII domain lids and a dinuclear metal center 2006 ·BMC Structural Biology ·Kumar Singh Saikatendu,Xuejun Zhang,Lisa N. Kinch,Matthew I. Leybourne,Nick V. Grishin,Hong Zhang	14
18	Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme 2006 ·Proceedings of the National Academy of Sciences ·Kiira Ratia,Kumar Singh Saikatendu,Bernard D. Santarsiero,Naina Barretto,Susan C. Baker,Raymond C. Stevens,Andrew D. Mesecar	332
19	Crystal Structure of Nonstructural Protein 10 from the Severe Acute Respiratory Syndrome Coronavirus Reveals a Novel Fold with Two Zinc-Binding Motifs 2006 ·Journal of Virology ·Jeremiah S. Joseph,Kumar Singh Saikatendu,Vanitha Subramanian,Benjamin W. Neuman,Alexei Brooun,Mark T. Griffith,Kin Moy,Maneesh K. Yadav,Jeffrey Velasquez,Michael J. Buchmeier,Raymond C. Stevens,Peter Kühn	94
20	Structural Basis of Severe Acute Respiratory Syndrome Coronavirus ADP-Ribose-1″-Phosphate Dephosphorylation by a Conserved Domain of nsP3 2005 ·Structure ·Kumar Singh Saikatendu,Jeremiah S. Joseph,Vanitha Subramanian,(unknown),Mark T. Griffith,Kin Moy,Jeffrey Velasquez,Benjamin W. Neuman,Michael J. Buchmeier,Raymond C. Stevens,Peter Kühn	157

About Kumar Singh Saikatendu

Kumar Singh Saikatendu is a scholar working on Infectious Diseases, Toxicology and Oncology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Protein Structure and Dynamics (4 papers) and Viral gastroenteritis research and epidemiology (4 papers). The work is most often cited by research in Infectious Diseases (775 citations), Animal Science and Zoology (279 citations) and Computational Theory and Mathematics (206 citations). Kumar Singh Saikatendu has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Raymond C. Stevens, Michael J. Buchmeier, Peter Kühn, Jeremiah S. Joseph, Benjamin W. Neuman, Vanitha Subramanian, Naina Barretto, Andrew D. Mesecar, Kiira Ratia and Susan C. Baker. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact